Holdings, Inc. (“ALX Oncology” or the “Company”), (Nasdaq: ALXO), a clinical-stage biotechnology company advancing therapies ...

PT/4:00 p.m. ET will review updated data from trial evaluating CD47-blocker evorpacept in HER2-positive gastric cancer SOUTH ...

Holdings announced the appointment of Harish Shantharam, CFA, as Chief Financial Officer, CFO. In addition, the company ...

Vornado Realty Trust (NYSE: VNO), the manager which conducts Alexander’s operations, announced it will host its quarterly earnings conference call and an audio webcast on Tuesday, February 11, 2025 at ...

ALX Africa is arguably one of the world’s biggest accelerators for high-quality tech and entrepreneurial skill programs at a ...

ALX Oncology Holdings Inc. (NASDAQ:ALXO), a biopharmaceutical company currently valued at $93.36 million, has announced the adoption of a new equity incentive plan, effective January 16, 2025. The ...

ALX Oncology Holdings Inc. (NASDAQ:ALXO – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the six analysts that are presently covering the firm, Marketbeat.com reports.

ALX Oncology Holdings Inc. (NASDAQ:ALXO – Get Free Report) insider Jaume Pons sold 10,796 shares of the firm’s stock in a transaction on Monday, December 30th. The shares were sold at an average price ...

Check the time stamp on this data. Updated AI-Generated Signals for Alexander's Inc. (ALX) available here: ALX. Type a few ...

Hyper Light Breaker early access officially arrives January 14, and to celebrate, Heart Machine Games have released a new ...

**NM signifies a non meaningful value. A dash signifies the data is not available.